Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2579 (LINC02579)

Target
LINC02579
Molecular classification
Long noncoding RNA (lncRNA), Long intergenic noncoding RNA (lincRNA), Other (noncoding RNA gene)
01

Overview

Long intergenic non-protein coding RNA 2579 (LINC02579) is a human gene encoding a long noncoding RNA molecule located in intergenic regions without protein coding capacity[1]. LINC02579 is classified as a lincRNA, a subclass of long noncoding RNAs transcribed by RNA polymerase II that often have capped and polyadenylated structures similar to mRNAs[7]. Though its individual biological roles are not well described, the lincRNA family is implicated in a wide spectrum of gene regulatory processes, including epigenetic modification, chromatin remodeling, transcriptional and post-transcriptional regulation, and serving as scaffolds for protein complexes[7]. As of current knowledge, there is no evidence linking LINC02579 to specific diseases, therapeutic indications, or drug interactions[1]. Data on this molecule is limited to its identification as a gene; no functional, clinical, or pharmacological applications have been validated at this time.

Other names
LINC02579AC007365.1Long intergenic non-protein coding RNA 2579
02

Mechanism of action

There are no clinically relevant drugs targeting LINC02579, so no mechanism of action applies

03

Biological functions

Transcriptional regulationChromatin remodelingEpigenetic regulationRNA stabilizationScaffolding for protein complexes
04

Safety considerations

No notable safety concerns or therapeutic challenges are reported, as LINC02579 is not currently a therapeutic target

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2579 (LINC02579).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2579 (LINC02579).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call